Literature DB >> 24421500

Issues facing pharmacy leaders in 2013.

Michael O'Connor1, Robert J Weber2.   

Abstract

The Director's Forum provides directors of pharmacy practical ways to develop patient-centered pharmacy services. Pharmacy directors must understand the key issues facing their departments and incorporate strategies for these issues as part of their strategic planning process. Health care reform and the Affordable Care Act require that departments operate efficiently and closely monitor their drug expense. The American Society of Health-System Pharmacists' Pharmacy Practice Model Initiative will serve as a valuable resource during 2013 to enhance the pharmacy practice model. By using their health care workforce, particularly pharmacy technicians, in an innovative way, pharmacy directors will allow the pharmacists to increase their clinical activity. By promoting the role of the hospital pharmacist to patients, directors will help to improve patients' understanding of their medications and increase their satisfaction with their care. Finally by changing the activities of pharmacy students in practice models, the patient care role of the pharmacist can be expanded. Through a greater understanding of the issues facing them and their effect on the operations of the pharmacy, pharmacy directors will learn effective ways to develop patient-centered pharmacy services.

Entities:  

Year:  2013        PMID: 24421500      PMCID: PMC3839473          DOI: 10.1310/hpj4805-433

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  7 in total

1.  Best possible medication history by a pharmacy technician at a tertiary care hospital.

Authors:  Shahileen Remtulla; Glen Brown; Luciana Frighetto
Journal:  Can J Hosp Pharm       Date:  2009-09

2.  American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice.

Authors:  John E Murphy; Jean M Nappi; John A Bosso; Joseph J Saseen; Brian A Hemstreet; Mary Ann Halloran; Sarah A Spinler; Timothy E Welty; Paul P Dobesh; Lingtak-Neander Chan; Cory G Garvin; Patricia E Grunwald; Claudia A Kamper; Cynthia A Sanoski; Paul L Witkowski
Journal:  Pharmacotherapy       Date:  2006-05       Impact factor: 4.705

3.  "Tech-check-tech": a review of the evidence on its safety and benefits.

Authors:  Alex J Adams; Steven J Martin; Samuel F Stolpe
Journal:  Am J Health Syst Pharm       Date:  2011-10-01       Impact factor: 2.637

4.  Council of Deans Report to AACP Board of Directors, July 21-22, 2016.

Authors: 
Journal:  Am J Pharm Educ       Date:  2016-12-25       Impact factor: 2.047

5.  Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013.

Authors:  James M Hoffman; Edward Li; Fred Doloresco; Linda Matusiak; Robert J Hunkler; Nilay D Shah; Lee C Vermeulen; Glen T Schumock
Journal:  Am J Health Syst Pharm       Date:  2013-03-15       Impact factor: 2.637

6.  Medicaid program; payment adjustment for provider-preventable conditions including health care-acquired conditions. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2011-06-06

7.  Enhancing pharmacy practice models through pharmacists' privileging.

Authors:  Benjamin Philip; Robert J Weber
Journal:  Hosp Pharm       Date:  2013-02
  7 in total
  4 in total

1.  Redesign of the Clinical Pharmacy Practice Model in a Tertiary Academic Hospital in Medellín, Colombia.

Authors:  Juan Pablo Botero Aguirre; Andrés Felipe Valencia Quintero; Elkyn Johan Granados Vega
Journal:  Can J Hosp Pharm       Date:  2017-06-30

2.  Profiles in Leadership: Clifton J. Latiolais, MSc, DSc.

Authors:  Sara White; Harold N Godwin; Robert J Weber
Journal:  Hosp Pharm       Date:  2013-09

3.  Profiles in Leadership: Donald E. Francke, MSc, DSc (Hon).

Authors:  James G Stevenson; Rachel E Beham; Robert J Weber
Journal:  Hosp Pharm       Date:  2013-10

4.  Issues facing pharmacy leaders in 2014: suggestions for pharmacy strategic planning.

Authors:  Anand Khandoobhai; Robert J Weber
Journal:  Hosp Pharm       Date:  2014-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.